As expected, and by design, LHCs were significantly different from T2DM subjects in age, body composition, systolic blood pressure, and glucose metabolism with the exception for fasting insulin and steady‐state plasma insulin (90–120 min) during the hyperinsulinemic‐euglycemic clamp. This evidence concerns the gene INS and type 2 diabetes mellitus.